Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers.

Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers. Curr Med Res Opin. 2017 Apr 20;:1-16 Authors: D'Arcy Y, McCarberg B, Parsons B, Behar R, Thorpe A, Alexander A Abstract Neuropathic pain (NeP) is a distinct type of pain caused by damage to the nervous system itself. This often severe and chronic type of pain requires specific treatments that target the underlying pain pathophysiology. The purpose of the current narrative review is to provide an overview of pregabalin (Lyrica®) for the treatment of NeP including its effects on pain, pain-related sleep interference, and other health-related outcomes, timing of therapeutic effect, safety and tolerability, and dosing. The information provided here, along with that in our companion review [1], will help primary care providers develop more effective NeP treatment strategies. PMID: 28426255 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research